Portfolio Company · Operating Co.

NewLeaf Symbiotics

A new class of microbial amendments
NewLeaf Symbioticsbacked byLewis & Clark Partners
CurrentA new class of microbial amendments

Company Snapshot

NewLeaf Symbiotics is a a new class of microbial amendments portfolio company held by Lewis & Clark Partners. Profile compiled from public sources; submit updates to extend the public record.

SectorA new class of microbial amendments
Ownership statusCurrent
Website

Ownership Context

NewLeaf Symbiotics is a current portfolio company of Lewis & Clark Partners. Public coverage of this company is grouped under its parent firm's profile.

Sources

https://lewisandclarkpartners.com/portfolio
This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with NewLeaf Symbiotics and does not provide investment advice.

Other portfolio companies of Lewis & Clark Partners

See the full Lewis & Clark Partners portfolio.